Posts for the 'Digitek' Category

Digoxin Lawsuit Consolidation in West Virginia

Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R. Goodwin.

Read the rest of this entry »

Following Digitek recall, Actavis issues recall for 65 other drugs made at same plant

On Monday, Actavis Totowa, LLC, the maker of Digitek, recalled over 65 different generic drugs made at their New Jersey manufacturing plant. Following an FDA inspection earlier this year, a number of violations of good manufacturing practices were identified. In April 2008, Actavis issued a Digitek recall for all lots of their generic digoxin which were made at the same plant, after they discovered that tablets had been commercially sold which were twice as thick as they were supposed to be.

>>PRIOR POST (5/4/2008): Digitek Recall Due to Risk of Digoxin Overdose

Read the rest of this entry »

Digitek Overdose Lawsuits: Double strength tablets increased risk of digitalis toxicity

The lawyers at Saiontz, Kirk & Miles, P.A. are investigating potential Digitek overdose lawsuits for individuals who experienced digitalis toxicity resulting in severe injuries or the need for medical treatment. Manufacturing defects allowed certain Digitek (digoxin) tablets to be sold with twice the appropriate amount of ingredient, increasing the risk of a digoxin overdose.

Read the rest of this entry »

Digitek lawsuits have been filed and more cases are coming

Less than two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being investigated throughout the country by individuals who are trying to determine if they may be entitled to compensation through a Digitek lawsuit.

Read the rest of this entry »

Ethex Morphine Recall due to risk of Morphine Overdose

A nationwide Ethex morphine recall was issued yesterdat for 60 mg extended release morphine sulfate tablets. It was discovered that certain pills sold may contain up to double the appropriate medication and be twice as thick as normal. The recall lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Ethex morphine lawsuits for individuals who suffered a morphine overdose or death while taking the medication.

>>FDA LINK: Ethex Morphine Sulfate Recall

Read the rest of this entry »

Extent of Digitek Problems remains unclear

It has been over three weeks since a nationwide Digitek recall was issued after it was discovered that some tablets could contain twice the appropriate strength. However, very little information has been released about the extent of the Digitek problems and exactly how long double strength tablets have been sold.

Read the rest of this entry »

Digitek Class Action Lawsuits filed

Two weeks after a nationwide Digitek recall, several class action lawsuits have already been filed on behalf of users who took the heart drug. Manufacturing problems resulted in some tablets being sold with twice as much of the active medication as they were supposed to have. While Digitek class action suits are seeking reimbursement for the cost of the prescription medication and funding for medical monitoring, those who have suffered severe injuries or death after taking Digitek, should consider pursuing an individual lawsuit.

Read the rest of this entry »

Digitek recall letters being sent by pharmacies

Following last weeks Digitek recall, people are receiving phone calls and pharmacy letters notifying them that their heart drug may be unsafe. All lots of the Digitek, a generic form of digoxin, were removed from shelves after it was discovered that some tablets could contain twice the appropriate amount of the active drug. This could increase the risk of digitalis toxicity, a serious and potentially fatal illness. In an unusual move, pharmacists are being required to attempt to notify all customers who filled a prescription.

>>FDA LINK: Generic Digoxin Recall

Read the rest of this entry »

Digitek Recall due to risk of Digitalis Toxicity

Last week Actavis Totowa announced a nationwide Digitek recall due to manufacturing defects which caused some of the digoxin tablets to contain double the appropriate amount of active ingredients. This could lead to a substantial risk of a serious and potentially fatal illness, known as digitalis toxicity, especially among those with renal failure. The lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Digitek recall lawsuits throughout the United States.

Read the rest of this entry »

Additional Information and Lawsuit Resources

MRI Lawsuit
MRI Contrast Lawsuits

Gadolinium contrast used during MRI and MRA could cause Nephrogenic Systemic Fibrosis (NSF) among those with kidney problems.

More MRI Lawsuit Info

Chantix Lawsuits
Chantix Suicide Problems

Anti-smoking drug Chantix side effects could increase the risk of suicide or suicidal thoughts which the manufacturer failed to adequately warn about.

More Chantrix Lawsuit Info

Yamaha Rhino Rollover Lawsuits
Yamaha Rhino Rollovers

The Yamaha Rhino is prone to rollover due to design defects. Lack of safety features and proper warnings have resulted in serious fractures and crush injuries for many riders.

More Yamaha Rhino Lawsuit Info

Shoulder Surgery Pump
Shoulder Pain Pump Lawsuits

Infusion pain pumps used following arthroscopic shoulder surgery have been linked to painful and debilitating cartilage loss.

More PAGCL Info